---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-031124"
form_type: "8-K"
ticker: "OTLC"
cik: "0000908259"
company_name: "Oncotelic Therapeutics, Inc."
filed_at: "2026-06-29T21:15:16+00:00"
generated_at: "2026-06-29T21:16:23.159122+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Oncotelic enters $178K convertible note financing with Pacific Pier Capital

## Summary
- Issued $178,410 convertible promissory note with 12% OID and 12% interest, maturing in 1 year.
- Conversion price: $0.06/share or 85% of lowest VWAP in prior 10 trading days.
- Net proceeds to Oncotelic ~$150,000 after buyer's $7,000 legal fee withholding.
- Issued 500,000 commitment shares as additional consideration to Pacific Pier.
- Prepayment allowed after 6 months; default interest rate of 16% upon event of default.

## SEC filing metadata
- accession: 0001493152-26-031124
- form_type: 8-K
- ticker: OTLC
- cik: 0000908259
- company_name: Oncotelic Therapeutics, Inc.
- filed_at: 2026-06-29T21:15:16+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/908259/000149315226031124/0001493152-26-031124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/908259/000149315226031124/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-031124
- JSON: https://secwatch.observer/filing/0001493152-26-031124.json
- Plain text: https://secwatch.observer/filing/0001493152-26-031124.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.